The health-related quality of life of drug-resistant tuberculosis patients receiving treatment in Botswana
DR-TB patients in Botswana demonstrated comparable or improved HRQoL (> 47 NBS) in their second year (13-24 months) of treatment, contrasting with poorer HRQoL scores in the initial and final years for both the PCS and MCS. The findings underscore the necessity for tailored psychosocial support, advocated for its integration into the Botswana National TB Program as a pilot initiative before widespread implementation.
Authors
- Kebayaone P. Gare (ORCID: https://orcid.org/0000-0002-3445-6626)
- Mooketsi Molefi (ORCID: https://orcid.org/0000-0002-6921-1186)
- Makamu Sebakeng (ORCID: https://orcid.org/0000-0002-1952-2269)
Institutions
- University of Botswana (BW)
- Ministry of Health (BW)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1186/s12879-024-10258-7
- Citations
- 3
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Office of Research and Development
- Office of Research and Development, University of Botswana